Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21 R-mediated JAK2/STAT3 pathway

被引:30
|
作者
Huang, Yanxia [1 ,2 ]
Zhang, Jing [2 ]
Wang, Ge [2 ]
Chen, Xiaoyu [2 ]
Zhang, Rui [2 ]
Liu, Hui [2 ]
Zhu, Jinshui [2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Gastroenterol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China
关键词
gastric cancer; growth; IL-21R; JAK2; oxymatrine; STAT3; INTERLEUKIN-21; RECEPTOR; IN-VITRO; GROWTH; CELLS; LYMPHOMA; PROLIFERATION;
D O I
10.1177/2058738418781634
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oxymatrine (OMT) as a type of alkaloids collected from Sophora flavescens Ait exerts some biological functions including anticancer properties. Here, we investigated the therapeutic effects of OMT in gastric cancer cells (HGC 27 and AGS). As a result, the exposure of gastric cancer (GC) cells to OMT contributed to the suppression of cell proliferation and invasion. Interleukin 21 receptor (IL-21R) was identified to be differentially expressed between OMT treatment group (4mg/mL) and control group (0 mg/mL), and knockdown of IL-21 R repressed cell proliferation and invasion via inactivation of the JAK2/STAT3 pathway. The rescue experiment showed that IL-21R overexpression attenuated the anti-tumor effects of OMT through activation of the JAK2/STAT3 pathway. Moreover, the expression of IL-21R was significantly upregulated in GC samples compared with the adjacent normal tissues and associated with overall survival (OS) and tumor recurrence of GC patients. Taken together, in this study, we evaluated the anti-tumor effects of OMT on GC by investigating proliferation and invasion ability changes, and our findings show that OMT exhibits effects via regulation of JAK/STAT signaling pathway. Through the mechanism study, we may enlighten the potential therapeutic target for treatment of GC.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo
    Judd, Louise M.
    Menheniott, Treve R.
    Ling, Hui
    Jackson, Cameron B.
    Howlett, Meegan
    Kalantzis, Anastasia
    Priebe, Waldemar
    Giraud, Andrew S.
    PLOS ONE, 2014, 9 (05):
  • [2] Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway
    Jiao, X. X.
    Lin, S. Y.
    Lian, S. X.
    Qiu, Y. R.
    Li, Z. H.
    Chen, Z. H.
    Lu, W. Q.
    Zhang, Y.
    Deng, L.
    Jiang, Y.
    Hu, G. H.
    NEOPLASMA, 2020, 67 (04) : 834 - 842
  • [3] Aurka Regulates STAT3 Activity Through JAK2 in Human Gastric and Esophageal Cancer
    Katsha, Ahmed M.
    Arras, Janet
    Belkhiri, Abbes
    El-Rifai, Wael
    GASTROENTEROLOGY, 2014, 146 (05) : S696 - S696
  • [4] Etomidate elicits anti-tumor capacity by disrupting the JAK2/STAT3 signaling pathway in hepatocellular carcinoma
    Xu, Jiali
    Zhang, Liren
    Li, Nana
    Dai, Jingjing
    Zhang, Ruizhi
    Yao, Feifan
    Zhou, Suiqing
    Wu, Zifeng
    Zhou, Huixuan
    Zhou, Ling
    Li, Qing
    Wang, Xuehao
    Liu, Cunming
    CANCER LETTERS, 2023, 552
  • [5] The anti-cancer mechanism of Celastrol by targeting JAK2/STAT3 signaling pathway in gastric and ovarian cancer
    Wu, Kang
    Qiu, Chentao
    Ma, Qihong
    Chen, Fangfang
    Lu, Tiangong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 491
  • [6] Inhibition of IARS alleviates skin inflammation in psoriasis through JAK2/STAT3 pathway
    Chen, X.
    Zheng, Y.
    Xu, F.
    Man, X.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S158 - S158
  • [7] Quercetin exerts anti-tumor immune mechanism by regulating IL-6/JAK2/ STAT3 signaling pathway to deplete Treg cells
    Liao, Yupei
    Xie, Xiaoqing
    Zhang, Chu
    Zhong, Haijing
    Shan, Luchen
    Yu, Pei
    Xu, Lipeng
    TOXICON, 2024, 243
  • [8] OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
    Kim, Mi-Jung
    Nam, Hyun-Jin
    Kim, Hwang-Phill
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Oh, Do-Youn
    Bang, Yung-Jue
    CANCER LETTERS, 2013, 335 (01) : 145 - 152
  • [9] Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer
    Fan, Xuhui
    Fu, Haotian
    Xie, Ni
    Guo, Hangcheng
    Fu, Tiantian
    Shan, Yunfeng
    AGING-US, 2021, 13 (19): : 22830 - 22842
  • [10] Baicalein Enhances Radiosensitivity in Colorectal Cancer via JAK2/STAT3 Pathway Inhibition
    Yu, Qingqing
    Tang, Rongjun
    Mo, Weixing
    Zhao, Linfang
    Li, Lingdi
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 104 (02)